Randomized controlled study on combination therapy of tiotropium bromide and sustained-release theophyline for moderate stable COPD.

Trial Profile

Randomized controlled study on combination therapy of tiotropium bromide and sustained-release theophyline for moderate stable COPD.

Recruiting
Phase of Trial: Phase IV

Latest Information Update: 21 May 2012

At a glance

  • Drugs Tiotropium bromide (Primary) ; Theophylline
  • Indications Chronic obstructive pulmonary disease
  • Focus Adverse reactions; Therapeutic Use
  • Most Recent Events

    • 21 May 2012 Planned end date 31 Jan 2009 added as reported by Chinese Clinical Trial Register.
    • 26 Nov 2011 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top